Skip to main content
Premium Trial:

Request an Annual Quote

DNA Sciences, GlaxoSmithKline Study Links to Adverse Events

NEW YORK, June 17 - DNA Sciences and GlaxoSmithKline will collaborate to study SNPs related to certain drug-related adverse cardiovascular events, DNA Sciences said today.

 

Under the agreement, DNA Sciences will use its high-throughput sequencing and genotyping facility to study genetic variants that may predispose patients to so-called Long QT Syndrome, a potentially fatal adverse event brought on by more than 50 currently available medications.

 

Click here for more information.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.